Henrik Lofvall
Lund, M, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Generation of gene-corrected functional osteoclasts from osteopetrotic induced pluripotent stem cells.
Journal: Stem cell research & therapy
Published: February 20, 2020
Hematopoietic Stem Cell-Targeted Neonatal Gene Therapy with a Clinically Applicable Lentiviral Vector Corrects Osteopetrosis in oc/oc Mice.
Journal: Human gene therapy
Published: June 11, 2019
A dual amylin and calcitonin receptor agonist inhibits pain behavior and reduces cartilage pathology in an osteoarthritis rat model.
Journal: Osteoarthritis and cartilage
Published: November 12, 2018
Combining naproxen and a dual amylin and calcitonin receptor agonist improves pain and structural outcomes in the collagen-induced arthritis rat model.
Journal: Arthritis research & therapy
Published: July 30, 2018
Osteoclasts degrade bone and cartilage knee joint compartments through different resorption processes.
Journal: Arthritis research & therapy
Published: November 02, 2017
Protein biomarkers associated with pain mechanisms in osteoarthritis.
Journal: Journal of proteomics
Published: October 31, 2017
Targeting NSG Mice Engrafting Cells with a Clinically Applicable Lentiviral Vector Corrects Osteoclasts in Infantile Malignant Osteopetrosis.
Journal: Human gene therapy
Published: July 21, 2017
Forced expression of human macrophage colony-stimulating factor in CD34+ cells promotes monocyte differentiation in vitro and in vivo but blunts osteoclastogenesis in vitro.
Journal: European journal of haematology
Published: January 25, 2017
Regulation and Function of Lentiviral Vector-Mediated TCIRG1 Expression in Osteoclasts from Patients with Infantile Malignant Osteopetrosis: Implications for Gene Therapy.
Journal: Calcified tissue international
Published: June 29, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026